Publication | Closed Access

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293

Phase Ii TrialGastrointestinal OncologyProtocol E1293MedicineUpper Gastrointestinal TractPathologyMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer Research